Interestingly, a study has shown that RIF in obese individuals (not diagnosed with IBD) decreased proinflammatory adipokines such as TNF-α and IL6 (known to have a role in IBD), and promoted anti-inflammatory IL10 known to have a protective role in the intestinal mucosa [8]. The gene discussed is TNF; the disease is inflammatory bowel disease.